Analysis of PCa patient data revealed a strong positive correlation between EP300/CREBBP and NR3C1 (GR-gene) expression (Supplementary Fig. S4d), particularly in primary, AR-positive, and double-negative CRPC patients. The gene discussed is NR3C1; the disease is posterior cortical atrophy.